Increasing incidence of chronic diseases, government investments for cell-based research, the growing focus on personalized medicine, increasing focus on R&D for cell-based therapies, and growing GMP certifications for cell therapy production facilities.    Cell-based approaches, primarily using mesenchymal stromal cells (MSCs), offers a promising approach toward mitigating the...